SpecGx, LLC
SpecGx, LLC appears in FDA public data with 2 recalls, 0 510(k) clearances, 27 FDA inspections, and 0 compliance actions on record. Its most recent recall (D-0254-2026, Class II) was initiated on December 16, 2025.
Summary
- Total Recalls
- 2
- 510(k) Clearances
- 0
- Inspections
- 27
- Compliance Actions
- 0
Recent Recalls
| Number | Class | Product | Date |
|---|---|---|---|
| D-0254-2026 | Class II | Oxycodone and Acetaminophen CII Tablets USP, 10mg/325 mg, 100 tablets, Rx only, SpecGx LLC, Webster | December 16, 2025 |
| D-0255-2026 | Class II | Oxycodone and Acetaminophen CII Tablets USP, 7.5 mg/325 mg, 100 tablets, Rx only, SpecGx LLC, Webste | December 16, 2025 |